Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Share

Statistics for the 2023 & 2024 Europe Glucagon-Like Peptide-1 (GLP-1) Agonists market share, created by Mordor Intelligence™ Industry Reports. Europe Glucagon-Like Peptide-1 (GLP-1) Agonists share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Agonists Research Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Industry

The Europe GLP-1 market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., holding a presence in the region.

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Leaders

  1. Novo Nordisk

  2. AstraZeneca

  3. Eli lilly and Company

  4. Sanofi

  5. Pfizer

*Disclaimer: Major Players sorted in no particular order

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market Concentration

Europe GLP-1 Agonists Market Report Snapshots

Europe GLP-1 Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)